TAM
ARRY

Tocqueville Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Tocqueville Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-17,225
Closed -$420K – 810
2019
Q1 		$420K Buy
+17,225
New +$359K 0.01% 620
2018
Q3 		– Sell
-27,600
Closed -$463K – 859
2018
Q2 		$463K Buy
27,600
+15,100
+121% +$240K 0.01% 617
2018
Q1 		$204K Buy
+12,500
New +$200K ﹤0.01% 787
2016
Q4 		– Sell
-100,000
Closed -$675K – 872
2016
Q3 		$675K Hold
100,000
– – 0.01% 575
2016
Q2 		$356K Hold
100,000
– – ﹤0.01% 694
2016
Q1 		$295K Sell
100,000
-250
-0.2% -$749 ﹤0.01% 733
2015
Q4 		$423K Buy
100,250
+10,000
+11% +$45.6K 0.01% 703
2015
Q3 		$412K Buy
90,250
+15,000
+20% +$88.9K 0.01% 752
2015
Q2 		$543K Buy
+75,250
New +$555K 0.01% 695
2014
Q3 		– Sell
-250
Closed -$1K – 1411
2014
Q2 		$1K Hold
250
– – ﹤0.01% 1709
2014
Q1 		$1K Hold
250
– – ﹤0.01% 1322
2013
Q4 		$1K Buy
+250
New +$1.36K ﹤0.01% 1333

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tocqueville Asset Management's ARRY Position: Q2 2019 in Review

Tocqueville Asset Management sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 17,225 shares — an estimated $420K sold.

Tocqueville Asset Management first reported a position in ARRY in Q4 2013 and held it in 12 quarters. The position peaked at $675K in Q3 2016. 318 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Tocqueville Asset Management reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Tocqueville Asset Management sold 17,225 Array Biopharma Inc shares in Q2 2019, an estimated $420K.
  • Tocqueville Asset Management first reported a position in Array Biopharma Inc in Q4 2013 and held it in 12 quarters.
  • Tocqueville Asset Management's Array Biopharma Inc position peaked at $675K in Q3 2016.
  • 318 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Tocqueville Asset Management's 13F filing for Q2 2019, filed 31 Jul 2019.